Jonathan Krant
Rheumatology · Peterborough, NHNPI 1023165172
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $257,670 of the $327,818 with a category attached, or 78.6%. AbbVie accounts for 64.9% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $74,295 and has fallen 95.5% since, to $3,341 in 2025. Among rheumatology clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 783 payments — averaging $418.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$213K
- Amgen$64K
- Novartis$38K
- Boehringer Ingelheim International GmbH$4K
- Vertex$2K
- Johnson & Johnson$1K
- plus $6K from 25 others
Across 44 payments — averaging $3883.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$145K
- Eli Lilly$26K
What the payments were for
- Consulting fees$26,7268%
- Speaking & faculty fees$257,67079%
- Travel & lodging$27,9849%
- Food & beverage$15,2345%
- Education$2040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 279 | $212,852 |
| Amgen(2 entities) | 185 | $63,735 |
| Novartis | 108 | $38,253 |
| Boehringer Ingelheim International GmbH | 2 | $3,997 |
| Vertex | 5 | $2,225 |
| Johnson & Johnson | 40 | $1,210 |
| UCB, Inc. | 46 | $1,037 |
| Tersera Therapeutics LLC | 1 | $580 |
| Dr.reddy's Laboratories,inc. | 1 | $580 |
| ZOLL Medical Corporation | 1 | $450 |
| E.r. Squibb & Sons, L.L.C. | 7 | $386 |
| Pfizer | 20 | $378 |
| Aurinia Pharma U.S., Inc. | 12 | $251 |
| Janssen Scientific Affairs, LLC | 3 | $222 |
| Genentech USA, Inc. | 6 | $168 |
| ANI Pharmaceuticals, Inc. | 8 | $167 |
| AstraZeneca | 8 | $162 |
| Boehringer Ingelheim | 3 | $161 |
| Lilly USA, LLC | 11 | $160 |
| GSK | 9 | $155 |
| Bristol Myers Squibb | 5 | $139 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $111 |
| Cardinal Health 110 LLC | 1 | $100 |
| Actelion Pharmaceuticals US, Inc. | 3 | $84 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $61 |
| Radius Health, Inc. | 4 | $58 |
| Endo Pharmaceuticals Inc. | 4 | $52 |
| Organon | 1 | $36 |
| Invivyd Inc | 1 | $21 |
| Bioventus LLC | 1 | $15 |
| Sobi, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$327,818 in reported general payments places this provider in the 95th percentile of 48 rheumatology providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $105,099 |
| Orencia ClickjectAbatacept | 17 | $101,345 |
| BenlystaBelimumab | 11 | $52,373 |
| Methylprednisolone | 54 | $1,129 |
| Hydroxychloroquine Sulfate | 30 | $944 |
| Pregabalin | 29 | $369 |
| Duloxetine Hcl | 24 | $294 |
| Prednisone | 55 | $287 |
| MethotrexateMethotrexate Sodium | 20 | $233 |
| Gabapentin | 14 | $148 |
| Naproxen | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBenlysta | $155 | $52,37311 claims |
| Dr.reddy's Laboratories,inc.Pregabalin | $580 | $36929 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 48 rheumatology providers in New Hampshire.
Other rheumatology in Peterborough
- William RigbyLebanon$83K
- Naureen MirzaManchester$67K
- Todd DaughertyHenniker$22K
- Jenny LinManchester$4K
- Brian McKinleyDover$3K
- Lindsey MacfarlaneLebanon$3K
- Vivekanand TiwariLebanon$2K
- Robert SimmsLebanon$2K
- Rui ZhangNashua$2K
- John GormanNashua$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.